title: Stable brain ATM message and residual kinase-active ATM protein in ataxia-telangiectasia.
abstract: The gene that is mutated in ataxia-telangiectasia (A-T), ATM, is catalytically activated in response to DNA damage. Yet a full accounting for the CNS deficits in human A-T or its mouse models remains elusive. We have analyzed the CNS phenotypes of two mouse Atm alleles--Atm(tm1Bal) (Bal) and Atm(tm1Awb) (Awb). Neither mutant has detectable mRNA or protein in peripheral tissues. In brain, although Bal/Bal mice have no ATM protein, they have nearly normal amounts of Atm mRNA. Bal/Bal neurons exhibit extensive cell cycle reentry and degeneration in both cortex and cerebellum. Unexpectedly, in Awb/Awb mice a novel mRNA is found in which the engineered mutation is excised. This mRNA is apparently translated and produces a catalytically active ATM protein that responds to DNA damage by phosphorylating p53 and Chk2. Prompted by these results, we examined eight cases of human A-T and found evidence for residual ATM protein in seven of them. These findings offer important new insights into the human disease and the role of brain ATM activity in the severity of the neurological symptoms of A-T.
authors: Department of Cell Biology and Neuroscience, Nelson Biological Laboratories, Rutgers University, Piscataway, New Jersey 08854, USA. Jli@dls.rutgers.edu
authors: Jiali
authors: J
authors: Li
authors: Jianmin
authors: J
authors: Chen
authors: Harry V
authors: HV
authors: Vinters
authors: Richard A
authors: RA
authors: Gatti
authors: Karl
authors: K
authors: Herrup
references: J Neurosci. 2006 Jul 19;26(29):7767-74
references: 16855104
references: Proc Natl Acad Sci U S A. 2000 Jan 18;97(2):871-6
references: 10639172
references: Int J Radiat Biol. 1994 Dec;66(6 Suppl):S23-9
references: 7836849
references: Annu Rev Immunol. 1997;15:177-202
references: 9143686
references: Genes Dev. 1996 Oct 1;10(19):2411-22
references: 8843194
references: Pediatrics. 1958 Apr;21(4):526-54
references: 13542097
references: Science. 1998 May 15;280(5366):1089-91
references: 9582124
references: EMBO J. 2006 Aug 9;25(15):3504-14
references: 16858402
references: Am J Med Genet. 2000 May 29;92(3):170-7
references: 10817650
references: Hum Mol Genet. 1999 Jan;8(1):69-79
references: 9887333
references: Proc Natl Acad Sci U S A. 1996 Nov 12;93(23):13084-9
references: 8917548
references: Proc Natl Acad Sci U S A. 1997 Nov 11;94(23):12688-93
references: 9356511
references: Birth Defects Orig Artic Ser. 1975;11(1):255-70
references: 1096982
references: Proc Natl Acad Sci U S A. 2000 Mar 28;97(7):3336-41
references: 10716718
references: J Neurosci. 2005 Mar 9;25(10):2522-9
references: 15758161
references: Nature. 1988 Dec 8;336(6199):577-80
references: 3200306
references: Mol Genet Metab. 2003 Dec;80(4):437-43
references: 14654357
references: Am J Med Genet A. 2007 Aug 15;143A(16):1827-34
references: 17632790
references: Curr Biol. 2009 Dec 29;19(24):2091-6
references: 19962314
references: Science. 1995 Jun 23;268(5218):1749-53
references: 7792600
references: Gynecol Oncol. 1989 Feb;32(2):257-60
references: 2910790
references: Cell. 1996 Jul 12;86(1):159-71
references: 8689683
references: Neurology. 1960 Jul;10:705-15
references: 14444443